Abstract
Although medications with glucagon-like peptide-1 (GLP-1) receptor agonist activity have transformed the management of obesity and shown substantial cardiometabolic benefits, unmet needs remain. Su...
Cite
CITATION STYLE
APA
le Roux, C. W., Wharton, S., Startseva, E., Kloer, I. M., Hussain, S. A., Unseld, A., … Kaplan, L. M. (2026). Survodutide Once Weekly for the Treatment of Adults with Obesity. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2600751
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free